ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.320,96
0,33%
S&P 500
5.631,22
0,28%
US Dollar vs BRL
5,4486
0,01%
Bitcoin
62.856,81
-3,08%
Brent Oil
83,695
-0,76%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Champions Oncology Inc (CSBR)

  7. Champions Oncology Inc (CSBR) Notícias

CSBR

Champions Oncology (CSBR)

Champions Oncology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR
DataHoraFonteTítuloCódigoCompanhia
06/05/202420:46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CSBRChampions Oncology Inc
12/02/202423:12Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CSBRChampions Oncology Inc
16/01/202413:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSBRChampions Oncology Inc
13/12/202318:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSBRChampions Oncology Inc
12/12/202318:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSBRChampions Oncology Inc
12/12/202307:50IH Market NewsHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and MoreNASDAQ:CSBRChampions Oncology Inc
28/08/202316:14Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CSBRChampions Oncology Inc
28/08/202316:12Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CSBRChampions Oncology Inc
24/07/202317:17Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CSBRChampions Oncology Inc
10/12/201819:30PR Newswire (US)Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018NASDAQ:CSBRChampions Oncology Inc
07/11/201811:30PR Newswire (US)Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select ConferenceNASDAQ:CSBRChampions Oncology Inc
13/09/201817:05PR Newswire (US)Champions Oncology Reports Record Quarterly Revenue of $6.2 MillionNASDAQ:CSBRChampions Oncology Inc
13/09/201809:30PR Newswire (US)Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New YorkNASDAQ:CSBRChampions Oncology Inc
28/08/201809:30PR Newswire (US)Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018NASDAQ:CSBRChampions Oncology Inc
08/08/201809:30PR Newswire (US)Champions Oncology Granted Full Accreditation by the AAALACNASDAQ:CSBRChampions Oncology Inc
26/07/201817:02PR Newswire (US)Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018NASDAQ:CSBRChampions Oncology Inc
12/07/201809:30PR Newswire (US)Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018NASDAQ:CSBRChampions Oncology Inc
18/06/201809:30PR Newswire (US)Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PD...NASDAQ:CSBRChampions Oncology Inc
03/05/201809:30PR Newswire (US)Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9thNASDAQ:CSBRChampions Oncology Inc
01/05/201809:30PR Newswire (US)Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology ResearchNASDAQ:CSBRChampions Oncology Inc
04/04/201809:30PR Newswire (US)Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex HouseNASDAQ:CSBRChampions Oncology Inc
15/03/201817:01PR Newswire (US)Champions Oncology Reports Quarterly Revenue of $5.1 MillionNASDAQ:CSBRChampions Oncology Inc
07/03/201810:30PR Newswire (US)Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018NASDAQ:CSBRChampions Oncology Inc
26/02/201810:30PR Newswire (US)Champions Oncology to Participate at the 30th Annual ROTH ConferenceNASDAQ:CSBRChampions Oncology Inc
21/02/201810:30PR Newswire (US)Motivated Patients with ROS1 Cancer Initiate Global Research StudyNASDAQ:CSBRChampions Oncology Inc
07/12/201719:15PR Newswire (US)Champions Oncology Reports Record Quarterly Revenue of $5.2 MillionNASDAQ:CSBRChampions Oncology Inc
28/11/201711:05PR Newswire (US)Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017NASDAQ:CSBRChampions Oncology Inc
07/11/201711:00PR Newswire (US)Champions Oncology to Participate in the Craig-Hallum Alpha Select Investor ConferenceNASDAQ:CSBRChampions Oncology Inc
26/09/201709:30PR Newswire (US)Champions Oncology announces $2 million award from the National Cancer Institute (NCI) to develop and evaluate prostate cance...NASDAQ:CSBRChampions Oncology Inc
18/09/201710:15PR Newswire (US)Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model resp...NASDAQ:CSBRChampions Oncology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
INBR32
Inter &
BOV
GFSA3
GAFISA ON
BOV
AZEV4
AZEVEDO PN
BOV
AMER3
Americanas ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados